Literature DB >> 2786706

Glycated fibrinogen: a new index of short-term diabetic control.

M R Hammer1, P N John, M D Flynn, A J Bellingham, R D Leslie.   

Abstract

Fibrinogen is a plasma protein with a short half-life of four days and, therefore, glycated fibrinogen may be valuable as an index of short-term diabetic control. We have developed a simple, rapid method for determining glycated fibrinogen using affinity chromatography. The differences in the percentage of glycated fibrinogen between normal subjects, well-controlled diabetics and poorly-controlled diabetics were highly significant. There was a significant correlation between glycated fibrinogen and glycated haemoglobin for all these subjects. However, in selected subjects with rapidly improving diabetic control the difference between the fall over three days in glycated fibrinogen and glycated haemoglobin was highly significant. In subjects with deteriorating control over an average of four weeks there was a significant difference between the increase in glycated fibrinogen and glycated haemoglobin. We suggest that glycated fibrinogen may be a valuable adjunct to glucose measurements in the assessment of short-term diabetic control due to its rapid change following alterations in control.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786706     DOI: 10.1177/000456328902600108

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  5 in total

Review 1.  Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulators.

Authors:  Vladimir N Uversky
Journal:  Front Mol Biosci       Date:  2014-07-25

2.  Association of fibrinogen level with early neurological deterioration among acute ischemic stroke patients with diabetes.

Authors:  Seong-Joon Lee; Ji Man Hong; Sung Eun Lee; Dae Ryong Kang; Bruce Ovbiagele; Andrew M Demchuk; Jin Soo Lee
Journal:  BMC Neurol       Date:  2017-05-19       Impact factor: 2.474

Review 3.  Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.

Authors:  Katherine Kearney; Darren Tomlinson; Kerrie Smith; Ramzi Ajjan
Journal:  Cardiovasc Diabetol       Date:  2017-03-09       Impact factor: 9.951

Review 4.  Intrinsic Disorder and Posttranslational Modifications: The Darker Side of the Biological Dark Matter.

Authors:  April L Darling; Vladimir N Uversky
Journal:  Front Genet       Date:  2018-05-04       Impact factor: 4.599

5.  Effects of glycemic control and hypoglycemia on Thrombus formation assessed using automated microchip flow chamber system: an exploratory observational study.

Authors:  Kiyoaki Yamamoto; Takashi Ito; Tomoka Nagasato; Atsushi Shinnakasu; Mihoko Kurano; Aiko Arimura; Hiroshi Arimura; Hiroshi Hashiguchi; Takahisa Deguchi; Ikuro Maruyama; Yoshihiko Nishio
Journal:  Thromb J       Date:  2019-09-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.